TauRx launch short animation on Tau pathology and Mode of Action of LMTM in Alzheimer's Disease
Building on previously launched educational materials, and in further collaboration with non-profit organisation BrainMind, their wonderful scientific illustrations have been transformed into a short animation. TauRx is excited to launch this, which summarises the result of decades of tau-based research from the TauRx team.
The animation has been designed to outline tau pathology and the mode of action of TauRx’s experimental drug, hydromethylthionine (LMTM) in Alzheimer’s Disease. View the animation and our other videos on our YouTube channel.